• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度哮喘剖析:年龄有何关联?来自意大利重度哮喘网络(SANI)队列的分析

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.

作者信息

Caminati Marco, Marcon Alessandro, Vaia Rachele, Senna Gianenrico, Maule Matteo, Marchetti Pierpaolo, Miotti Jessica, Argentino Giuseppe, Blasi Francesco, Canonica Giorgio W, Heffler Enrico M, Paggiaro Pierluigi, Vianello Andrea, Guarnieri Gabriella

机构信息

Department of Medicine, University of Verona, Verona, Italy.

Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.

出版信息

World Allergy Organ J. 2024 Jul 29;17(8):100941. doi: 10.1016/j.waojou.2024.100941. eCollection 2024 Aug.

DOI:10.1016/j.waojou.2024.100941
PMID:39176287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11338937/
Abstract

BACKGROUND

Aging implies changes in terms of lung function, immune system, and respiratory and extra-respiratory comorbidities. Few studies have specifically addressed the relevance of age on severe asthma burden and control. We aimed to evaluate whether age acts as an independent determinant of asthma severity, in terms of clinical, functional, and inflammatory profile, and to explore potential cofactors that contribute to a more difficult disease control in different age groups.

METHODS

Patients from Severe Asthma Network Italy (SANI) registry were retrospectively divided in subgroups according to their age. Cutoffs for age were established according to quartiles in order to obtain a comparable number of patients for each group, and then rounded for the sake of simplicity.

RESULTS

Overall, 1805 severe asthma patients were analyzed. Lung function represented the most important age-related variable. On the opposite the level of asthma control was not differently distributed among age ranges. In young people the presence of atopy-related comorbidities (allergic rhinitis, atopic dermatitis) predominated, whilst systemic-metabolic and degenerative comorbidities such as diabetes, cardiovascular diseases, anxious-depressive syndrome, and osteoporosis prevailed in elderly. Bronchiectasis and sleep disturbances were significantly associated with age.

CONCLUSIONS

Despite that it cannot be considered a treatable trait, our study suggests that age should be evaluated within a personalized approach to severe asthma patients, in order to provide a better clinical profiling and a more tailored treatment strategy.

摘要

背景

衰老意味着肺功能、免疫系统以及呼吸和呼吸外合并症方面的变化。很少有研究专门探讨年龄对重度哮喘负担和控制的相关性。我们旨在评估年龄是否作为哮喘严重程度的独立决定因素,从临床、功能和炎症特征方面进行评估,并探索导致不同年龄组疾病控制更困难的潜在辅助因素。

方法

来自意大利重度哮喘网络(SANI)登记处的患者根据年龄进行回顾性分组。根据四分位数确定年龄界限,以便每组获得可比数量的患者,然后为了简化进行四舍五入。

结果

总体上,分析了1805例重度哮喘患者。肺功能是与年龄相关的最重要变量。相反,哮喘控制水平在各年龄范围之间分布并无差异。在年轻人中,与特应性相关的合并症(过敏性鼻炎、特应性皮炎)占主导,而在老年人中,系统性代谢和退行性合并症如糖尿病、心血管疾病、焦虑抑郁综合征和骨质疏松症更为常见。支气管扩张和睡眠障碍与年龄显著相关。

结论

尽管年龄不能被视为一种可治疗的特征,但我们的研究表明,在对重度哮喘患者进行个性化治疗时应评估年龄,以便提供更好的临床概况和更具针对性的治疗策略。

相似文献

1
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.重度哮喘剖析:年龄有何关联?来自意大利重度哮喘网络(SANI)队列的分析
World Allergy Organ J. 2024 Jul 29;17(8):100941. doi: 10.1016/j.waojou.2024.100941. eCollection 2024 Aug.
2
The Severe Asthma Network in Italy: Findings and Perspectives.意大利严重哮喘网络:研究结果与展望。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1462-1468. doi: 10.1016/j.jaip.2018.10.016. Epub 2018 Oct 25.
3
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry.吸烟习惯在重度哮喘患者中的相关性:来自意大利重度哮喘网络(SANI)注册研究的证据。
J Clin Med. 2022 Dec 16;11(24):7465. doi: 10.3390/jcm11247465.
4
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.慢性鼻-鼻窦炎伴鼻息肉对重度哮喘患者的影响:来自意大利重度哮喘网络(SANI)登记研究的证据。
Respir Med. 2020 May;166:105947. doi: 10.1016/j.rmed.2020.105947. Epub 2020 Apr 2.
5
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry.与意大利严重哮喘网络(SANI)注册研究中医生诊断的支气管扩张症相关的临床特征。
Expert Rev Respir Med. 2021 Mar;15(3):419-424. doi: 10.1080/17476348.2021.1840983. Epub 2020 Nov 3.
6
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).IgE介导的过敏性疾病中变应原特异性免疫治疗指南:德国变态反应学与临床免疫学会(DGAKI)、儿科变态反应与环境医学学会(GPA)、德国变态反应科医生医学协会(AeDA)、奥地利变态反应与免疫学会(ÖGAI)、瑞士变态反应与免疫学会(SGAI)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNO-KHC)、德国儿科学与青少年医学学会(DGKJ)、儿科肺病学会(GPP)、德国呼吸学会(DGP)、德国耳鼻喉外科医生协会(BV-HNO)、儿科医生与青年医生专业联合会(BVKJ)、肺科医生联邦协会(BDP)以及德国皮肤科医生协会(BVDD)的S2k指南
Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2.
7
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
8
9
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry.真实生活中重度哮喘患者使用噻托溴铵的频率及临床特征:来自意大利重度哮喘网络(SANI)注册研究的数据
J Asthma Allergy. 2020 Nov 10;13:599-604. doi: 10.2147/JAA.S274245. eCollection 2020.
10

引用本文的文献

1
Identifying Treatable Traits of Patients with Asthma Prescribed an ICS/LABA: A Descriptive Analytic Database Study in England.识别使用吸入性糖皮质激素/长效β2受体激动剂治疗的哮喘患者的可治疗特征:一项在英国开展的描述性分析数据库研究
Adv Ther. 2025 Aug 19. doi: 10.1007/s12325-025-03332-2.

本文引用的文献

1
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.2 型炎症性疾病缓解:当前证据、未满足的需求以及慢性鼻-鼻窦炎伴鼻息肉缓解定义的建议。
Curr Allergy Asthma Rep. 2024 Jan;24(1):11-23. doi: 10.1007/s11882-023-01118-6. Epub 2023 Dec 12.
2
Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.靶向白细胞介素-5/5 受体生物制剂治疗伴有支气管扩张症的严重嗜酸性粒细胞性哮喘的真实世界疗效。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2724-2731.e2. doi: 10.1016/j.jaip.2023.05.041. Epub 2023 Jun 7.
3
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group.哮喘中的全身用糖皮质激素:世界变态反应组织和呼吸有效性小组的行动呼吁。
World Allergy Organ J. 2022 Dec 10;15(12):100726. doi: 10.1016/j.waojou.2022.100726. eCollection 2022 Dec.
4
Current Understanding of Asthma Pathogenesis and Biomarkers.当前对哮喘发病机制和生物标志物的认识。
Cells. 2022 Sep 5;11(17):2764. doi: 10.3390/cells11172764.
5
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry.与意大利严重哮喘网络(SANI)注册研究中医生诊断的支气管扩张症相关的临床特征。
Expert Rev Respir Med. 2021 Mar;15(3):419-424. doi: 10.1080/17476348.2021.1840983. Epub 2020 Nov 3.
6
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the ().生物制剂在重度哮喘中减少口服皮质类固醇的应用:()的评论
World Allergy Organ J. 2020 Sep 20;13(10):100464. doi: 10.1016/j.waojou.2020.100464. eCollection 2020 Oct.
7
Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.严重哮喘的最新进展:从表型到个体化医学。
Chest. 2020 Mar;157(3):516-528. doi: 10.1016/j.chest.2019.10.009. Epub 2019 Oct 31.
8
Outcome measures to be considered on asthma in elderly.用于评估老年哮喘的结局指标。
Curr Opin Allergy Clin Immunol. 2019 Jun;19(3):209-215. doi: 10.1097/ACI.0000000000000525.
9
Clinical characteristics and comorbidities of elderly asthmatics who attend allergy clinics.就诊于过敏诊所的老年哮喘患者的临床特征及共病情况。
Asthma Res Pract. 2018 Apr 23;4:5. doi: 10.1186/s40733-018-0041-x. eCollection 2018.
10
Airway Inflammation and Inflammatory Biomarkers.气道炎症和炎症生物标志物。
Semin Respir Crit Care Med. 2018 Feb;39(1):56-63. doi: 10.1055/s-0037-1606217. Epub 2018 Feb 10.